REFERENCES
1. Xanthos T, Giannakopoulos N, Papadimitriou L. Lipomatous hypertrophy
of the interatrial septum: a pathological and clinical approach.
International journal of cardiology. 2007;121(1):4-8.
2. Kılıçkap G. A case with a giant interatrial septal lipomatous
hypertrophy, and thickened epicardial and visceral fat: Different faces
of a common metabolic problem? Anatolian Journal of cardiology.
2018;19(6):417.
3. Rigatelli G, Dell’Avvocata F, Braggion G, Giordan M, Chinaglia M,
Cardaioli P. Persistent venous valves correlate with increased shunt and
multiple preceding cryptogenic embolic events in patients with patent
foramen ovale: an intracardiac echocardiographic study. Catheterization
and Cardiovascular Interventions. 2008;72(7):973-6.
4. Burke AP, Litovsky S, Virmani R. Lipomatous hypertrophy of the atrial
septum presenting as a right atrial mass. The American journal of
surgical pathology. 1996;20(6):678-85.
5. Kleiman AM, Harding LM, Bechtel AJ. Concomitant lipomatous
hypertrophy and left atrial mass: distinguishing benign from malignant.
Echocardiography. 2018;35(4):534-6.
6. Gopal DJ, Han Y, Silvestry FE, Ferrari VA. Atypical presentation of
lipomatous hypertrophy of the interatrial septum: a case report.
European Heart Journal: Case Reports. 2019;3(4):1.
7. Sparrow PJ, Kurian JB, Jones TR, Sivananthan MU. MR imaging of
cardiac tumors. Radiographics. 2005;25(5):1255-76.
8. Motwani M, Kidambi A, Herzog BA, Uddin A, Greenwood JP, Plein S. MR
imaging of cardiac tumors and masses: a review of methods and clinical
applications. Radiology. 2013;268(1):26-43.
9. Dong E. Hongru Du, and Lauren Gardner. 2020.“. An Interactive
Web-Based Dashboard to Track COVID-19 in Real Time.30120-1.
10. Esposito A, De Cobelli F, Ironi G, Marra P, Canu T, Mellone R, et
al. CMR in the assessment of cardiac masses: primary malignant tumors.
JACC: Cardiovascular Imaging. 2014;7(10):1057-61.